CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 372 enrolled
Drug / intervention
Contour Next and Contour TV3 BGMS testing by subjects with and without Diabetesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03730480
NCT03730480N/ACompleted

User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System

Ascensia Diabetes Care·interventional·Posted Nov 5, 2018·Updated Jan 18, 2022

In Brief

A clinical study evaluating Contour Next and Contour TV3 BGMS testing by subjects with and without Diabetes for Diabetes Mellitus. Completed, enrolled 372 participants across 2 sites.

Detailed Summary

This study will collect lay user ("subjects") and healthcare professional information on the performance of two different blood glucose monitors, the CONTOUR NEXT and the CONTOUR TV3, in people with and without diabetes. Each subject will use both meters, at different times and in different order, using a fingerstick(s) to collect meter samples. Meter results will be compared to standardized test system to assess the accuracy of the meters' results. Additionally, a blood sample will be drawn from the subject's arm by a trained healthcare professional for testing on both BGMS. Subjects will also be asked to complete a questionnaire to rate their experience using the meters and to evaluate the meter's Instructions for Use. After all testing and the first questionnaire have been completed, the study staff will demonstrate only to subjects with diabetes several features of the meters that would not necessarily be experienced during the meter testing. These subjects will then answer questions about the features in a second questionnaire.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 5, 2018
Enrollment StartSep 6, 2018
Primary CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.7 years ago

Interventions

Contour Next and Contour TV3 BGMS testing by subjects with and without Diabetesdevice

Using the first blood glucose monitoring system (BGMS), which is either Contour Next or Contour TV3, subjects perform self fingerstick test and alternative site test on the palm. Staff performs fingerstick test on subject. Using the second BGMS, the palm, self test and staff tests are performed. Subjects with diabetes get a venipuncture and staff tests using both BGMS using the venous blood.